Rhythm Pharmaceuticals
Latest round
- Series B
Last raised
- Dec 2012
Total raised
- $41M
Investors
- 5
About Rhythm Pharmaceuticals
Founded in 2008 and based in Massachusetts, US, Rhythm Pharmaceuticals, Inc. is a biotechnology company that develops treatment for rare genetic diseases for chronic weight management in adult and pediatric patients six years of age and older with obesity. In October 2017, the company was listed on the Nasdaq global market for an IPO (Initial Public Offering) under the ticker symbol RYTM. Former CFO Hunter Smith took over the position in March of the same year, and in July 2020, David Meeker was appointed as Rhythm Pharmaceuticals' CEO.S. Food & Drug Administration (FDA) has approved Rhythm Pharmaceuticals' IMCIVREE (setmelanotide) in November 2020. In March 2024, Rhythm Pharmaceuticals, Inc. The company's R&D team offers clinical trials and translational research for setmelanotide, a melanocortin-4 receptor (MC4R) agonist used to treat rare genetic overweight disorders by optimizing DNA (deoxyribonucleic acid) sequencing infrastructure from individuals with severe obesity.
Who invested in Rhythm Pharmaceuticals
5 investors across 4 rounds
See all investors in Rhythm Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Rhythm Pharmaceuticals
Who invested in Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals has 5 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rhythm Pharmaceuticals raised?
Rhythm Pharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Rhythm Pharmaceuticals last raise money?
Rhythm Pharmaceuticals's most recent round on record is a Series B, in Dec 2012.
What does Rhythm Pharmaceuticals do?
Founded in 2008 and based in Massachusetts, US, Rhythm Pharmaceuticals, Inc.
Where is Rhythm Pharmaceuticals headquartered?
Rhythm Pharmaceuticals is headquartered in Boston, US.
Which VCs invest in companies like Rhythm Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Rhythm Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Rhythm Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.